Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review

被引:0
作者
Muir, Jeffrey M. [1 ]
Radhakrishnan, Amruta [1 ]
Stillman, Ipek Ozer [2 ]
Sarri, Grammati [3 ]
机构
[1] Cytel Inc, RWA Hlth Econ, Toronto, ON, Canada
[2] Takeda Pharmaceut, Value Evidence & Hlth Econ, Lexington, MA USA
[3] Cytel Inc, RWA Hlth Econ, London, England
来源
CLINICOECONOMICS AND OUTCOMES RESEARCH | 2024年 / 16卷
关键词
health technology assessment; health equity; cost-effectiveness analysis; value elements; umbrella review; ECONOMIC-EVALUATION; PUBLIC-HEALTH; DEFINING ELEMENTS; CARE; JUSTICE; PREFERENCES; ALLOCATION; EFFICIENCY; DISEASE;
D O I
10.2147/CEOR.S471827
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cost-effectiveness analyses (CEA) are important in healthcare decision-making and resource allocation; however, expanding the scope of CEAs beyond the traditional clinicoeconomic concepts to also include value elements such as health equity has attracted much interest in recent years. This umbrella review aimed to synthesize evidence on how equity concepts have been considered in modified types of CEAs. Publicly available articles in MEDLINE were searched on January 25, 2024, to identify systematic reviews (SLRs) published in English since 2013 that incorporate health equity considerations in CEAs. Title/abstract, fulltext article screening and data extraction were conducted by a single reviewer and validated by a second reviewer. Results were qualitatively synthesized to identify common themes. Eight SLRs were included. Distributional CEAs (DCEA), equity-based weighting, extended CEA (ECEA), mathematical programming and multi-criteria decision analysis (MCDA) were the most discussed approaches. A lack of consensus on the best approach for incorporating health equity into CEAs was highlighted, as these approaches are not currently consistently used in decision-making. Important limitations included scarcity of robust data to inform health equity indices, bias associated with commonly used health outcome metrics and the challenge of accounting for additional contextual factors such as fairness and opportunity costs. Proposals to expand CEAs to address equity issues come with challenges due to data unavailability, methods complexity, and decision-makers unfamiliarity with these approaches. Our review indicates that extended and distributional CEAs can support decision-making by capturing the impact of inequity on the clinical and cost-effectiveness assessment of treatments, although future modeling should account for additional contextual factors such as fairness and opportunity costs. Recommendations for actions moving forward include standardization of data collection for outcomes related to equity and familiarity with methodologies to account for the complexities of integrating health equity considerations in CEAs.
引用
收藏
页码:581 / 596
页数:16
相关论文
共 52 条
  • [1] An umbrella review of intersectoral and multisectoral approaches to health policy
    Amri, Michelle
    Chatur, Ali
    'Campo, Patricia
    [J]. SOCIAL SCIENCE & MEDICINE, 2022, 315
  • [2] DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF HEALTH CARE PROGRAMMES - A METHODOLOGICAL CASE STUDY OF THE UK BOWEL CANCER SCREENING PROGRAMME
    Asaria, Miqdad
    Griffin, Susan
    Cookson, Richard
    Whyte, Sophie
    Tappenden, Paul
    [J]. HEALTH ECONOMICS, 2015, 24 (06) : 742 - 754
  • [3] Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review
    Avancena, Anton L., V
    Prosser, Lisa A.
    [J]. VALUE IN HEALTH, 2021, 24 (01) : 136 - 143
  • [4] Incorporating Equity-Efficiency Interactions in Cost-Effectiveness Analysis-Three Approaches Applied to Breast Cancer Control
    Baeten, Stefan A.
    Baltussen, Rob M. P. M.
    Uyl-de Groot, Carin A.
    Bridges, John
    Niessen, Louis W.
    [J]. VALUE IN HEALTH, 2010, 13 (05) : 573 - 579
  • [5] Priority setting of health interventions: The need for multi-criteria decision analysis
    Baltussen R.
    Niessen L.
    [J]. Cost Effectiveness and Resource Allocation, 4 (1)
  • [6] Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward
    Baltussen, Rob
    Marsh, Kevin
    Thokala, Praveen
    Diaby, Vakaramoko
    Castro, Hector
    Cleemput, Irina
    Garau, Martina
    Iskrov, Georgi
    Olyaeemanesh, Alireza
    Mirelman, Andrew
    Mobinizadeh, Mohammedreza
    Morton, Alec
    Tringali, Michele
    van Til, Janine
    Valentim, Joice
    Wagner, Monika
    Youngkong, Sitaporn
    Zah, Vladimir
    Toll, Agnes
    Jansen, Maarten
    Bijlmakers, Leon
    Oortwijn, Wija
    Broekhuizen, Henk
    [J]. VALUE IN HEALTH, 2019, 22 (11) : 1283 - 1288
  • [7] Development of a checklist to guide equity considerations in health technology assessment
    Benkhalti, Maria
    Espinoza, Manuel
    Cookson, Richard
    Welch, Vivian
    Tugwell, Peter
    Dagenais, Pierre
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [8] Equity weights in the allocation of health care: the rank-dependent QALY model
    Bleichrodt, H
    Diecidue, E
    Quiggin, J
    [J]. JOURNAL OF HEALTH ECONOMICS, 2004, 23 (01) : 157 - 171
  • [9] Defining equity in health
    Braveman, P
    Gruskin, S
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (04) : 254 - 258
  • [10] Cheng MY, 2023, VALUE HEALTH, V26, pS275